In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Verily

Califf Confident Public Trust In US FDA Will Be Rebuilt

Commissioner nominee strikes an optimistic note as former FDA heads raise concerns about the decrease in agency credibility during the pandemic.

FDA Leadership

Amgen Joins AI/ML Gold Rush With Generate Deal

Deal Snapshot: At a same-day conference, Amgen’s CEO outlined the importance of AI/ML to the company’s drug development strategy, as numerous large biopharma companies have recently made similar deals.

Artificial Intelligence Deals

Google’s Verily Signs First Drug Discovery Pact With Sosei Heptares

Efforts to map disease using big data computing and speed drug discovery are gathering pace, with Verily among a wave of life science-focused tech companies.

Clinical Trials Companies

Questions To Califf In Second Confirmation Hearing Similar To Predecessors

However, the few Senate questions about industry ties, tobacco and food issues may surprise some observers.

FDA Leadership
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
    • Glucose Testing
  • Biotechnology
    • Nanotechnology, Chips, etc.
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Other Names / Subsidiaries
    • Alphabet Inc.
    • Verily Life Sciences LLC
UsernamePublicRestriction

Register